Immunomodulatory medicines for multiple sclerosis: Progress and prospects

[摘要]：Multiple sclerosis (MS) is a neurodegenerative disease with a major inflammatory component that constitutes the most common progressive and disabling neurological condition in young adults. Current therapies are mainly biological agents (beta-interferons,

[全文传递流程]：

一般上传文献全文的时限在1个工作日内